Luigi Costa
Président chez PinCell Srl
Postes actifs de Luigi Costa
Sociétés | Poste | Début | Fin |
---|---|---|---|
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Président | 07/05/2020 | - |
Historique de carrière de Luigi Costa
Anciens postes connus de Luigi Costa
Sociétés | Poste | Début | Fin |
---|---|---|---|
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Directeur Général | - | 21/06/2023 |
Fondateur | - | 21/06/2023 | |
THOR MEDICAL | Directeur Général | 01/09/2014 | 20/04/2018 |
ONCOPEPTIDES AB | Directeur/Membre du Conseil | 01/01/2016 | - |
Independent Dir/Board Member | 01/01/2016 | - | |
Amgen SAS
Amgen SAS Medical DistributorsDistribution Services Amgen SAS manufactures and distributes medicines. It specializes in biopharmaceutical products for diseases in the fields of oncology, cardiology, rheumatology, and nephrology. The company was founded in 1990 and is headquartered in Boulogne-Billancourt, France. | Directeur Général | - | - |
Amgen Dompé SpA
Amgen Dompé SpA Miscellaneous Commercial ServicesCommercial Services Amgen Dompé SpA wholesales pharmaceutical products. The company is headquartered in Milan, Italy. | Directeur Général | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Formation de Luigi Costa
University of Parma | Undergraduate Degree |
SDA Bocconi School of Management | Masters Business Admin |
Statistiques
Internationale
Italie | 5 |
Etats-Unis | 3 |
Suède | 2 |
Opérationnelle
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
AMGEN INC. | Health Technology |
ONCOPEPTIDES AB | Health Technology |
Entreprise privées | 6 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Amgen Dompé SpA
Amgen Dompé SpA Miscellaneous Commercial ServicesCommercial Services Amgen Dompé SpA wholesales pharmaceutical products. The company is headquartered in Milan, Italy. | Commercial Services |
Amgen SAS
Amgen SAS Medical DistributorsDistribution Services Amgen SAS manufactures and distributes medicines. It specializes in biopharmaceutical products for diseases in the fields of oncology, cardiology, rheumatology, and nephrology. The company was founded in 1990 and is headquartered in Boulogne-Billancourt, France. | Distribution Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Health Technology |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Health Technology |
- Bourse
- Insiders
- Luigi Costa
- Expérience